Article: CAELYX(R) Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer.

Article: Metastatic disease is relatively common in cases of breast ...
CME: Your SA Journal of CPD;  October 1, 2008 ;     700+ words ... ... drugs for the treatment of metastatic breast cancer will soon be registered ... palliative care. Treatment of metastatic breast cancer is given on an individual ... care. In a nutshell * Metastatic breast cancer treatment is not curative ...

Article: Video: Cities and States Around the U.S. Recognize October 13 as ...
PR Newswire;  October 13, 2009 ;     700+ words ... ... Recognize the Underrepresented Metastatic Breast Cancer Community NEW YORK, Oct ... experiences of those living with metastatic breast cancer (MBC), the most advanced ... advocates nationwide and the Metastatic Breast Cancer Network, United States ...

Article: CAELYX Demonstrates Efficacy and Reduced Cardiac Toxicity in ...
PR Newswire;  March 11, 2004 ;     700+ words ... ... first-line treatment of metastatic breast cancer with significantly reduced ... CAELYX in the treatment of metastatic breast cancer represent an important ... monotherapy for the treatment of metastatic breast cancer in women who are at cardiac ...

Article: Schering-Plough Announces EU Approval of CAELYX(R) in ...
PR Newswire;  January 14, 2003 ;     700+ words ... ... hydrochloride) as monotherapy for metastatic breast cancer in patients who are at ... active agents used to treat metastatic breast cancer. Additionally, CAELYX ... with end-stage, or metastatic breast cancer, five-year survival ...

Article: CAELYX and Herceptin Combination Shows Activity With Limited ...
PR Newswire;  June 5, 2004 ;     700+ words ... ... HER-2 positive(1) metastatic breast cancer (MBC). Findings from ... active agents for treating metastatic breast cancer, combining an anthracycline ... with end-stage, or metastatic breast cancer, five-year survival ...

Article: Schering-Plough Reports European Union's CPMP Recommends Approval ...
PR Newswire;  October 18, 2002 ;     700+ words ... ... hydrochloride) as monotherapy for metastatic breast cancer in patients who are at ... active agents used to treat metastatic breast cancer. Additionally, CAELYX ... with end-stage, or metastatic breast cancer, five-year survival ...

Article: FDA Grants Approval for Lilly's Gemzar(R) in Combination with ...
PR Newswire;  May 19, 2004 ;     700+ words ... ... therapy for women battling metastatic breast cancer. The FDA's approval ... Patients diagnosed with metastatic breast cancer and treated with a combination ... treatment of patients with metastatic breast cancer after failure of prior ...